Troponin i and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: The choices for healthy outcomes in caring for ESRD (CHOICE) study

American Journal of Kidney Diseases

Volumn 64, Issue 3, 2014, Pages 443-451

  Shafi, Tariq ^a,b   Zager, Philip G ^c   Sozio, Stephen M ^a,b   Grams, Morgan E ^a,b   Jaar, Bernard G ^a,b,d   Christenson, Robert H ^e   Boulware, L Ebony ^f   Parekh, Rulan S ^g   Powe, Neil R ^h   Coresh, Josef ^a,b,i  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d NEPHROLOGY CENTER OF MARYLAND   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

dialysis; End stage renal disease (ESRD); epidemiology; hemodialysis; hypertension; mortality; N terminal pro brain natriuretic peptide (NT proBNP); outcomes; systolic blood pressure; troponin I

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TROPONIN I;

ADULT; AGE DISTRIBUTION; ARTICLE; ASSOCIATION; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE;

DIALYSIS; END-STAGE RENAL DISEASE (ESRD); EPIDEMIOLOGY; HEMODIALYSIS; HYPERTENSION; MORTALITY; N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP); OUTCOMES; SYSTOLIC BLOOD PRESSURE; TROPONIN I;

BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TROPONIN I;

EID: 84908129333     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.03.015     Document Type: Article

References (32)

1. A.V. Chobanian, G.L. Bakris, and H.R. Black et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 6 2003 1206 1252
2. R. Agarwal, A.R. Nissenson, D. Batlle, D.W. Coyne, J.R. Trout, and D.G. Warnock Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States Am J Med 115 4 2003 291 297
3. 2010 Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1999-2008 2010 Arbor Research Collaborative for Health Ann Arbor, MI http://www.dopps.org/annualreport/html/MCOMHTN-c-mostrec2010.htm Accessed September 17, 2013
4. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients Am J Kidney Dis 45 4 suppl 3 2005 S16 S153
5. B.M. Robinson, L. Tong, and J. Zhang et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study Kidney Int 82 5 2012 570 580
6. K. Kalantar-Zadeh, R.D. Kilpatrick, C.J. McAllister, S. Greenland, and J.D. Kopple Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions Hypertension 45 4 2005 811 817
7. T.I. Chang, G.D. Friedman, A.K. Cheung, T. Greene, M. Desai, and G.M. Chertow Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO Study J Hum Hypertens 25 2 2011 98 105
8. E. Lacson Jr., and J.M. Lazarus The association between blood pressure and mortality in ESRD - not different from the general population? Semin Dial 20 6 2007 510 517
9. M.R. Weir Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Con position J Am Soc Hypertens 6 6 2012 443 447
10. N.W. Levin, P. Kotanko, and K.U. Eckardt et al. Blood pressure in chronic kidney disease stage 5D - report from a Kidney Disease: Improving Global Outcomes Controversies Conference Kidney Int 77 4 2010 273 284
11. T. Shafi, S. Waheed, and P.G. Zager Hypertension in hemodialysis patients: an opinion-based update Semin Dial 27 2 2014 146 153
12. J.A. de Lemos Increasingly sensitive assays for cardiac troponins: a review JAMA 309 21 2013 2262 2269
13. H.-N. Kim, and J.L. Januzzi Natriuretic peptide testing in heart failure Circulation 123 18 2011 2015 2019
14. K. Winkler, C. Wanner, C. Drechsler, J. Lilienthal, W. Marz, and V. Krane Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients Eur Heart J 29 17 2008 2092 2099
15. C. Zoccali, F. Mallamaci, and F.A. Benedetto et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients J Am Soc Nephrol 12 7 2001 1508 1515
16. F.S. Apple, M.M. Murakami, L.A. Pearce, and C.A. Herzog Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease Circulation 106 23 2002 2941 2945
17. N.R. Powe, M.J. Klag, and J.H. Sadler et al. Choices for Healthy Outcomes in Caring for End Stage Renal Disease Semin Dial 9 1 1996 9 11
18. J.C. Longenecker, M.J. Klag, and S.M. Marcovina et al. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients J Am Soc Nephrol 16 6 2005 1794 1802
19. D.C. Miskulin, K.B. Meyer, and N.V. Athienites et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease Am J Kidney Dis 39 2 2002 324 336
20. V.A. Nicolaos, C.M. Dana, and F. Gladys et al. Comorbidity assessment in hemodialysis and peritoneal dialysis using the Index of Coexistent Disease Semin Dial 13 5 2000 320 326
21. F.E. Harrell Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 Springer New York, NY
22. D.C. Wheeler, and G.J. Becker Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 83 3 2013 377 383
23. M.J. Klag, P.K. Whelton, and B.L. Randall et al. Blood pressure and end-stage renal disease in men N Engl J Med 334 1 1996 13 18
24. R.S. Vasan, M.G. Larson, and E.P. Leip et al. Impact of high-normal blood pressure on the risk of cardiovascular disease N Engl J Med 345 18 2001 1291 1297
25. K.J. Rothman, and S. Greenland Modern Epidemiology 2nd ed. 1998 Lippincott, Williams & Wilkins Philadelphia, PA
26. G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, and C. Zoccali Bias in clinical research Kidney Int 73 2 2008 148 153
27. M. Rahman, V. Griffin, A. Kumar, F. Manzoor, J.T. Wright Jr., and M.C. Smith A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients Am J Kidney Dis 39 6 2002 1226 1230
28. R. Agarwal Managing hypertension using home blood pressure monitoring among haemodialysis patients - a call to action Nephrol Dial Transplant 25 6 2010 1766 1771
29. R. Agarwal Blood pressure and mortality among hemodialysis patients Hypertension 55 3 2010 762 768
30. J.C. Longenecker, J. Coresh, and M.J. Klag et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE Study. Choices for Healthy Outcomes in Caring for ESRD J Am Soc Nephrol 11 3 2000 520 529
31. O.M. Gutierrez, H. Tamez, and I. Bhan et al. N-Terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements Clin Chem 54 8 2008 1339 1348
32. C.W. McIntyre, J.O. Burton, and N.M. Selby et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow Clin J Am Soc Nephrol 3 1 2008 19 26 Kidney Diseases Kidney Diseases Kidney Diseases Kidney Diseases